A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland
Authors:
Open Access
- 7 June 2019
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (4) , 825-830
Abstract
The good availability of medicines and medicine shortages have become global issues during recent years. Medicine shortages are often affected by universal determinants, but the availability of medicines is also depending on national characteristics. This commentary aims to discuss the issue of the availability of medicines and medicine shortages in outpatient care in Finland, taking in consideration both national characteristics and global determinants that effect on the availability of medicines in other countries but Finland also. In this commentary, a regulatory approach is applied.Keywords
This publication has 5 references indexed in Scilit:
- The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in FinlandPLOS ONE, 2017
- "How Can We Talk about Patient-centered Care without Patients at the Table?" Lessons Learned from Patient Advisory CouncilsThe Journal of the American Board of Family Medicine, 2016
- Medicine shortages – A study of community pharmacies in FinlandHealth Policy, 2015
- Drug Prices in Finland2014
- Patient and public involvement in the early stages of clinical trial development: a systematic cohort investigationBMJ Open, 2014